The global injectable drug delivery market is projected to grow from USD 690.23 billion in 2025 to USD 1,034.78 billion by 2030, representing a compound annual growth rate of 8.4% during the forecast period, MarketsandMarkets said. Growth is being supported by the rising prevalence of diabetes, cancer, cardiovascular diseases and autoimmune disorders, increased demand for biologics, advances in injectable formulations and wider adoption of devices such as prefilled syringes, autoinjectors, pen injectors, wearable injectors and needle-free systems. Formulations were the largest product segment in 2024, autoimmune diseases the leading therapeutic application, hospitals and clinics the largest end-user segment, and North America the largest regional market. Novel drug delivery systems, self-injection devices and partnerships are identified as the fastest growth opportunities. The report also highlights smart and connected injectors, large-volume subcutaneous delivery, microneedles, sustainable systems and pharmaceutical-device collaborations as important areas of development.